An Influenza Resistance Information Study (IRIS)
| Status: | Completed |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 1 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2009 |
| End Date: | November 2015 |
An Open Label Study to Examine Natural Prevalence and/or Emergence of Resistance to Antivirals Among Influenza Virus Isolates, and of the Clinical Outcome of Patients With Influenza: Influenza Resistance Information Study (IRIS)
This study will assist in the early detection of influenza resistant to antivirals, and will
monitor the clinical outcome of patients infected with influenza according to subtype and
susceptibility. Patients clinically diagnosed with influenza will undergo a rapid diagnostic
test, and viral sampling at baseline and on days 3 and 6. Patients will be clinically
managed according to local guidelines (no treatment, or treatment with neuraminidase
inhibitors or other appropriate therapies).
monitor the clinical outcome of patients infected with influenza according to subtype and
susceptibility. Patients clinically diagnosed with influenza will undergo a rapid diagnostic
test, and viral sampling at baseline and on days 3 and 6. Patients will be clinically
managed according to local guidelines (no treatment, or treatment with neuraminidase
inhibitors or other appropriate therapies).
Inclusion Criteria:
- patients>=1 year of age;
- symptoms suggestive of influenza-like illness including, but not limited to, fever,
cough or coryza.
Exclusion Criteria:
- allergy to any potential influenza therapy;
- more than one patient from same household or residential/care home.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials